Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 1;12:829812. doi: 10.3389/fonc.2022.829812

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 D’Auria, Statuto, Rago, Montagna, Castaldo, Schirò, Zeccola, Virgilio, Bianchino, Traficante, Sgambato, Fusco, Valvano and Calice

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Boxplots of the percentages, among total lymphocytes, of total T, B, NK, Tregs, T CD4, and T CD8 cells of the entire group of prostate cancer patients (44) undergoing curative RT. The data shown evidenced variations statistically significant during the four time points considered (Kruskal–Wallis test, p-value < 0.05), except for T CD8+ cells that did not undergo significant changes. t0: before RT; t1: end of RT; t2: 3 months after RT; t3: 6 months after RT.